BCMA-targeted immunotherapy for multiple myeloma

Yu, B; Jiang, TB; Liu, DL

Liu, DL (corresponding author), New York Med Coll, Dept Med, Valhalla, NY 10595 USA.; Liu, DL (corresponding author), Westchester Med Ctr, Valhalla, NY 10595 USA.

JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020; 13 (1):

Abstract

B cell maturation antigen (BCMA) is a novel treatment target for multiple myeloma (MM) due to its highly selective expression in malignant plasma cell......

Full Text Link